Bayer's ability to reassess its conglomerate structure is contingent upon resolving the ongoing Roundup weedkiller litigation. Bloomberg posted on X, highlighting that a settlement could pave the way for the company to explore strategic changes. The litigation has been a significant factor in Bayer's current operational focus, and its resolution could open new avenues for the company's future direction.
$GIGGLE – Relief bounce into supply after a clean downtrend. Short $GIGGLE Entry: 30.5 – 31.2 SL: 32.6 TP1: 28.8 TP2: 26.9 TP3: 25.5 The push higher stalled quickly and sell pressure showed up on the first test, suggesting this move is corrective rather than a trend shift. Momentum is rolling over and buyers aren’t getting acceptance above this zone, keeping downside continuation in play. Trade $GIGGLE LE here 👇
One of my best trades to date — executed with precision, patience, and a solid strategy. Perfect entry, disciplined hold, clean exit! #PEPE #btc #MarketPullback